These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3278857)
21. Mitochondrial dysfunction in uremic cardiomyopathy. Taylor D; Bhandari S; Seymour AM Am J Physiol Renal Physiol; 2015 Mar; 308(6):F579-87. PubMed ID: 25587120 [TBL] [Abstract][Full Text] [Related]
22. Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. Fabris B; Fischetti F; Carretta R; Narducci P; Piccinini C; Calci M; Biagi A; Candido R; Bardelli M; Campanacci L J Hypertens Suppl; 1993 Dec; 11(5):S344-5. PubMed ID: 8158415 [No Abstract] [Full Text] [Related]
23. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. Rodrigue ME; Lacasse-M S; Larivière R; Lebel M Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546 [TBL] [Abstract][Full Text] [Related]
24. Spontaneously occurring hypertrophic cardiomyopathy in the rat. II. Distribution of, and correlations between, various cardiac abnormalities in the WKY/NCrj and its related strains. Kuribayashi T; Mizuta T; Shimoo K; Kubota Y; Katsume H; Nakagawa M; Ibata Y Jpn Circ J; 1988 Oct; 52(10):1156-70. PubMed ID: 3210293 [TBL] [Abstract][Full Text] [Related]
25. Four-week oral toxicity study of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in uremic rats. Gomez M; Domingo JL; del Castillo D; Llobet JM; Corbella J Vet Hum Toxicol; 1995 Aug; 37(4):346-8. PubMed ID: 8540226 [TBL] [Abstract][Full Text] [Related]
26. A rat model for the study of growth failure in uremia. Chantler C; Lieberman E; Holliday MA Pediatr Res; 1974 Feb; 8(2):109-13. PubMed ID: 4810508 [No Abstract] [Full Text] [Related]
27. Dilated cardiomyopathy in acromegaly. O'Keefe JC; Wiseman JC; Wilmshurst EG Aust N Z J Med; 1985 Feb; 15(1):79-80. PubMed ID: 3859273 [No Abstract] [Full Text] [Related]
28. Hemodynamics of uremic anemia. Neff MS; Kim KE; Persoff M; Onesti G; Swartz C Circulation; 1971 Jun; 43(6):876-83. PubMed ID: 4931294 [No Abstract] [Full Text] [Related]
29. Contribution of systemic blood pressure to myocardial remodeling in uremic rats. Fabris B; Carretta R; Fischetti F; Candido R; Calci M; Castellano M; Bardelli M; Campanacci L Hypertension; 1995 Aug; 26(2):321-6. PubMed ID: 7635542 [TBL] [Abstract][Full Text] [Related]
31. Uremia in rats with normal kidneys: a model for the study of renal function in a uremic environment. Emmanouel DS; Lindheimer MD; Katz AI Kidney Int; 1977 Mar; 11(3):209-12. PubMed ID: 846073 [No Abstract] [Full Text] [Related]
33. Insulin resistance and altered glucose transporter 4 expression in experimental uremia. Aksentijević D; Bhandari S; Seymour AM Kidney Int; 2009 Apr; 75(7):711-8. PubMed ID: 19177156 [TBL] [Abstract][Full Text] [Related]
34. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats. Larivière R; Moreau C; Rodrigue ME; Lebel M Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):103-9. PubMed ID: 15207526 [TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone and the altered vascular response to norepinephrine in uremia. Collins J; Massry SG; Campese VM Am J Nephrol; 1985; 5(2):110-3. PubMed ID: 3993699 [TBL] [Abstract][Full Text] [Related]
36. Testicular function in experimental uremia. Handelsman DJ; Spaliviero JA; Turtle JR Endocrinology; 1985 Nov; 117(5):1974-83. PubMed ID: 3930220 [TBL] [Abstract][Full Text] [Related]
37. Low dose L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Poli de Figueiredo CE; Pinheiro da Costa BE; Comerlato L; Micheli E; Barros E Nephrol Dial Transplant; 2001 Oct; 16(10):2110-1. PubMed ID: 11572912 [No Abstract] [Full Text] [Related]
38. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Dumont Y; D'Amours M; Lebel M; Larivière R Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268 [TBL] [Abstract][Full Text] [Related]
39. Growth hormone and insulin-like growth factor in non-uremic acidosis and uremic acidosis. Kuemmerle N; Krieg RJ; Latta K; Challa A; Hanna JD; Chan JC Kidney Int Suppl; 1997 Mar; 58():S102-5. PubMed ID: 9067956 [TBL] [Abstract][Full Text] [Related]
40. Electrocardiographic abnormalities and uremic cardiomyopathy. Stewart GA; Gansevoort RT; Mark PB; Rooney E; McDonagh TA; Dargie HJ; Stuart R; Rodger C; Jardine AG Kidney Int; 2005 Jan; 67(1):217-26. PubMed ID: 15610245 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]